IMPL - Impel Pharmaceuticals Inc
Close
0.2411
-0.173 -71.796%
Share volume: 858,521
Last Updated: Fri 15 Dec 2023 10:00:01 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$0.41
-0.17
-41.79%
Summary score
36%
Profitability
40%
Dept financing
28%
Liquidity
40%
Performance
35%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-48.21%
Return on assets
-30.21%
Return on sales
-3662.84%
Return on invested capital
172.23%
Total debt ratio
150.95%
Debt ratio change over timeo
5.07%
Current Ratio
4.04%
Quick Ratio
3.85%
Cash Position Ratio
3.51%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
29.44%
Return on assets
-32.13%
Return on sales
-347.22%
Return on invested capital
127.3%
Total debt ratio
250.3%
Debt ratio change over timeo
14.93%
Current Ratio
1.6%
Quick Ratio
1.38%
Cash Position Ratio
1.11%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
15.03%
Return on assets
-36.53%
Return on sales
-255.05%
Return on invested capital
12.21%
Total debt ratio
362.04%
Debt ratio change over time
28.64%
Current Ratio
0.19%
Quick Ratio
0.13%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-58.27%
Return on assets
-186.65%
Return on sales
-3097.86%
Return on invested capital
410.44%
Total debt ratio
506.95%
Debt ratio change over time
5.07%
Current Ratio
4.25%
Quick Ratio
3.65%
Cash Position Ratio
2.9%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IMPL | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -48.21% | 7.58% | 36.15% | 7.75% |
| Return on assets | -30.21% | 2.95% | 3.44% | 5.85% |
| Return on sales | -3662.84% | 30.63% | 35.3% | 41.32% |
| Return on invested capital | 172.23% | 3.7% | 6.05% | 20.44% |
| Profitability | 25% | 37% | 62% | 58% |
| Total debt ratio | 150.95% | 92.36% | 89.3% | 27.07% |
| Debt ratio change over time | 5.07% | 292.67% | 15.45% | 1.02% |
| Dept financing | 25% | 40% | 16% | 5% |
| Current Ratio | 1.6% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 1.38% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 1.11% | 0.3% | 1.72% | 2.75% |
| Liquididy | 74% | 18% | 28% | 62% |
| Short-term ratios | IMPL | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 29.44% | 11.57% | 35.05% | 4.21% |
| Return on assets | -32.13% | 2.86% | 2.7% | 3.6% |
| Return on sales | -347.22% | 27.99% | 31.88% | 33.53% |
| Return on invested capital | 127.3% | 2.16% | 6.93% | 9.79% |
| Profitability | 46% | 49% | 69% | 55% |
| Total debt ratio | 250.3% | 89.83% | 93.1% | 22.12% |
| Debt ratio change over time | 14.93% | 102.83% | 13.09% | 1.3% |
| Dept financing | 29% | 34% | 12% | 3% |
| Current Ratio | 1.6% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 1.38% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 1.11% | 0.3% | 1.72% | 2.75% |
| Liquididy | 25% | 12% | 40% | 75% |